Elizabeth Cermak
Director/Board Member bei MOLECULIN BIOTECH, INC.
Vermögen: - $ am 31.03.2024
Profil
Elizabeth A.
Cermak currently works at Moleculin Biotech, Inc., as Independent Director from 2020.
Ms. Cermak also formerly worked at Clarus Therapeutics, Inc., as Independent Director, SteadyMed Therapeutics, Inc., as Director from 2015 to 2018, SteadyMed Ltd., as External Director from 2015 to 2018, QUE Oncology, Inc., as Independent Director, Ocean Ridge Charities Association, Inc., as Director, Neurana Pharmaceuticals, Inc., as Director, Clarus Therapeutics Holdings, Inc., as Independent Director from 2021 to 2022, Johnson & Johnson, as Vice President-Professional Sales & Marketing, POZEN, Inc., as Chief Commercial Officer & Executive VP from 2009 to 2013, and McNeil Consumer & Specialty Pharmaceuticals, Inc., as Vice President-Business Development.
Ms. Cermak received her Masters Business Admin degree from Drexel University and undergraduate degree from Franklin & Marshall College.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
MOLECULIN BIOTECH, INC.
-.--% | 26.12.2023 | 0 ( -.--% ) | - $ | 31.03.2024 |
Aktive Positionen von Elizabeth Cermak
| Unternehmen | Position | Beginn |
|---|---|---|
| MOLECULIN BIOTECH, INC. | Director/Board Member | 02.10.2020 |
Ehemalige bekannte Positionen von Elizabeth Cermak
| Unternehmen | Position | Ende |
|---|---|---|
| CLARUS THERAPEUTICS HOLDINGS, INC. | Director/Board Member | 31.10.2022 |
SteadyMed Therapeutics, Inc.
 SteadyMed Therapeutics, Inc. Medical/Nursing ServicesHealth Services Steadymed Therapeutics, Inc. develops drug delivery therapeutics devices. The company was founded by Amir Genosar, Ian Solomon and Gideon Kahana in 2005 and is headquartered in San Ramon, CA. | Director/Board Member | 01.09.2018 |
| STEADYMED LTD | Director/Board Member | 30.08.2018 |
| POZEN INC. | Corporate Officer/Principal | 01.01.2013 |
Neurana Pharmaceuticals, Inc.
 Neurana Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Neurana Pharmaceuticals, Inc. engages in a biotechnology industry. It focused on the development of drugs to treat neuromuscular disorders. The company was founded in 2013 and is headquartered in San Diego, CA. | Director/Board Member | - |
Ausbildung von Elizabeth Cermak
| Drexel University | Masters Business Admin |
| Franklin & Marshall College | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| JOHNSON & JOHNSON | Health Technology |
| MOLECULIN BIOTECH, INC. | Health Technology |
| CLARUS THERAPEUTICS HOLDINGS, INC. | Health Technology |
| Private Unternehmen | 8 |
|---|---|
POZEN, Inc.
 POZEN, Inc. Pharmaceuticals: MajorHealth Technology POZEN, Inc. manufactures and markets pharmaceutical products. Its Pipeline products are PA Product Portfolio, which is focused on integrated aspirin therapies that enable the full power of aspirin by reducing its potential gastrointestinal damage. The firm PA Product Portfolio consists of PA8140 and PA32540. The company was founded by John R. Plachetka in 1996 and is headquartered in Raleigh, NC. | Health Technology |
Clarus Therapeutics, Inc.
 Clarus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Clarus Therapeutics, Inc. operated as a men's health specialty pharmaceutical company that focuses on the development and commercialization of oral testosterone replacement therapy. It offered JATENZO, a soft gel oral formulation of testosterone undecanoate for treating hypogonadal men. The company was founded by Robert E. Dudley in February 2004 and was headquartered in Northbrook, IL. | Health Technology |
McNeil Consumer & Specialty Pharmaceuticals, Inc.
 McNeil Consumer & Specialty Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology McNeil Consumer & Specialty Pharmaceuticals manufactures and markets pain relievers. The firm makes over-the-counter products including fever reducers, Motrin and St. Joseph's Aspirin, gastrointestinal relievers, Imodium, and Mylanta. The company was founded on March 17, 1879 and is headquartered in Fort Washington, PA. | Health Technology |
SteadyMed Therapeutics, Inc.
SteadyMed Therapeutics, Inc. Medical/Nursing ServicesHealth Services Steadymed Therapeutics, Inc. develops drug delivery therapeutics devices. The company was founded by Amir Genosar, Ian Solomon and Gideon Kahana in 2005 and is headquartered in San Ramon, CA. | Health Services |
SteadyMed Ltd.
 SteadyMed Ltd. Pharmaceuticals: MajorHealth Technology SteadyMed Ltd. was engaged in the research, development, and manufacture of pharmaceutical products through the PatchPump technology. Its portfolio included Trevyent for pulmonary arterial hypertension and At Home Patient Analgesia for post-surgical pains. The company was founded on June 15, 2005 and was headquartered in Rehovot, Israel. | Health Technology |
QUE Oncology, Inc.
 QUE Oncology, Inc. Pharmaceuticals: MajorHealth Technology QUE Oncology, Inc. engages in preventing and treating life-threatening cancers such as prostate cancer, breast cancer, melanoma, and cancer pain; and related conditions. The company is headquartered in Atlanta, GA. | Health Technology |
| Ocean Ridge Charities Association, Inc. | |
Neurana Pharmaceuticals, Inc.
Neurana Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Neurana Pharmaceuticals, Inc. engages in a biotechnology industry. It focused on the development of drugs to treat neuromuscular disorders. The company was founded in 2013 and is headquartered in San Diego, CA. | Health Technology |
